However, during the 6 months after the treatments were stopped, the IVIg group demonstrated more frequent worsening. This latter effect is important both because therapy in CIDP is usually ...

This systematic review demonstrated that IVIg and corticosteroids still provide the most effective first line treatment options for patients with active CIDP. The review also revealed there is a ...

The EAN/PNS treatment guideline calls for IVIG or corticosteroids as initial treatment in all CIDP types, with IVIG as the first-line treatment in motor CIDP. The choice of IVIG versus ...

Another study looked at how effective IVIG therapy was for CIDP. Participants received an IVIG or placebo infusion every ...

An important issue to our members is unfettered access to the lifesaving plasma protein therapy IVIG. Both GBS and CIDP are rare conditions that, when untreated, can cause debilitating pain and ...

the risk of CIDP worsening and requiring additional therapy after treatment discontinuation was higher with IVIg than with methylprednisolone (38% vs 0%; P =.03). The ICE trial accounted for ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & Nasdaq: ARGX) today announced that China’s National Medical ...

The Intravenous Immunoglobulin market has experienced remarkable growth over recent years, driven by advancements in medical ...

VYVGART Hytrulo is approved for CIDP as a once weekly 30-to-90 second subcutaneous injection. It is the first and only therapy approved in China for the treatment of CIDP, a debilitating ...

First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – 7:30am ET Amsterdam, the Netherlands— argenx SE ...